Hepatic veno-occlusive disease due to DTIC

Area of Science:

• Oncology
• Hepatology
• Toxicology

Background:

• Metastatic melanoma is a serious cancer diagnosis.
• Chemotherapy, including DTIC (dacarbazine), is a treatment option for metastatic melanoma.
• Drug-induced liver injury is a known, though often rare, complication of cancer therapies.

Observation:

• A patient undergoing DTIC treatment for metastatic melanoma developed sudden, severe liver failure.
• Autopsy findings showed extensive centrilobular necrosis in the liver, indicative of a veno-occlusive process.
• No similar pathology was observed in other organs, and common causes of liver necrosis were excluded.

Findings:

• The hepatic failure was attributed solely to DTIC (dacarbazine) toxicity.
• The observed pathology was a veno-occlusive process within the liver.
• This specific adverse event has been documented with other chemotherapeutic agents.

Implications:

• Physicians must be vigilant for potential fatal hepatic side effects of DTIC and similar chemotherapeutics.
• Early recognition and management of drug-induced veno-occlusive liver disease are critical.
• This case highlights the importance of monitoring liver function during chemotherapy for metastatic melanoma.